Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alzheimer's disease.

Roy Yaari1, Jody Corey-Bloom

  • 1Department of Neurosciences and the Alzheimer's Disease Research Center, University of California, San Diego, La Jolla, California 92161, USA.

Seminars in Neurology
|January 18, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential sensitivity of the MMSE and MoCA for staging and longitudinal cognitive change in Huntington's disease.

Journal of Huntington's disease·2026
Same author

Late-life body mass index and amyloid interaction on cognitive decline in unimpaired older adults.

The journal of prevention of Alzheimer's disease·2026
Same author

Increase in healthcare utilization and Medicare payment with progression of preclinical Alzheimer's disease.

The journal of prevention of Alzheimer's disease·2026
Same author

Toward a Speech-Based Model of Premanifest Huntington's Disease Progression Using Deep Neural Networks.

Digital biomarkers·2026
Same author

Capturing Behavioral Symptoms in Huntington's Disease Using the Huntington's Disease-Behavioral Questionnaire.

Movement disorders clinical practice·2026
Same author

Corrigendum to "Examining balance and the likelihood of falls in Huntington's disease". [Clin. Parkinsonism Relat. Dis. 13 (2025) 100399].

Clinical parkinsonism & related disorders·2026
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Alzheimer's disease (AD) is a leading cause of dementia, impacting millions and costing billions annually. Current treatments offer limited benefits, highlighting the need for better diagnostic tools and disease-modifying therapies for Alzheimer's disease.

Area of Science:

  • Neurology
  • Geriatrics
  • Public Health

Background:

  • Alzheimer's disease (AD) is the most prevalent form of dementia in older adults.
  • AD affects millions, with projections indicating a significant increase in cases by 2050.
  • The disease incurs substantial healthcare costs exceeding $100 billion yearly.

Purpose of the Study:

  • To summarize the current understanding of Alzheimer's disease, including its epidemiology, clinical presentation, and neuropathology.
  • To discuss the limitations of current diagnostic methods and therapeutic interventions for AD.
  • To emphasize the importance of supportive care for patients and caregivers.

Main Methods:

  • Clinical diagnosis based on cognitive and functional decline.
  • Identification of neuropathologic hallmarks: neuritic plaques and neurofibrillary tangles.

Related Experiment Videos

  • Review of current therapeutic approaches and their efficacy.

    • Main Results:

    • AD presents with progressive memory loss and affects cognitive functions like language and executive functioning.
    • Behavioral and psychiatric symptoms are common in AD patients.
    • Available therapies provide modest symptomatic relief but do not halt disease progression.

    Conclusions:

    • There is a critical need for improved diagnostic tools and disease-modifying treatments for Alzheimer's disease.
    • Caregiver support, including access to resources like adult day care and respite services, is essential.
    • Further research into AD pathogenesis and effective interventions is imperative.